ATE445704T1 - Expressionsvektor für tierische zellen - Google Patents

Expressionsvektor für tierische zellen

Info

Publication number
ATE445704T1
ATE445704T1 AT01957013T AT01957013T ATE445704T1 AT E445704 T1 ATE445704 T1 AT E445704T1 AT 01957013 T AT01957013 T AT 01957013T AT 01957013 T AT01957013 T AT 01957013T AT E445704 T1 ATE445704 T1 AT E445704T1
Authority
AT
Austria
Prior art keywords
vector
expression vector
present
animal cells
expression
Prior art date
Application number
AT01957013T
Other languages
English (en)
Inventor
Jong-Mook Kim
Jung-Seob Kim
Sun-Mo Oh
Jae-Seung Yoon
Kwang-Hee Baek
Soo-Il Chung
Doo-Hong Park
Yeup Yoon
Original Assignee
Mogam Biotech Res Inst
Neurotech Pharmaceuticals Co L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mogam Biotech Res Inst, Neurotech Pharmaceuticals Co L filed Critical Mogam Biotech Res Inst
Application granted granted Critical
Publication of ATE445704T1 publication Critical patent/ATE445704T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT01957013T 2000-07-29 2001-07-27 Expressionsvektor für tierische zellen ATE445704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0043996A KR100408844B1 (ko) 2000-07-29 2000-07-29 동물세포 발현벡터
PCT/KR2001/001285 WO2002014525A2 (en) 2000-07-29 2001-07-27 Expression vector using for animal cell

Publications (1)

Publication Number Publication Date
ATE445704T1 true ATE445704T1 (de) 2009-10-15

Family

ID=19680759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01957013T ATE445704T1 (de) 2000-07-29 2001-07-27 Expressionsvektor für tierische zellen

Country Status (10)

Country Link
US (1) US7422874B2 (de)
EP (1) EP1392835B1 (de)
JP (1) JP4138479B2 (de)
KR (1) KR100408844B1 (de)
CN (1) CN1262663C (de)
AT (1) ATE445704T1 (de)
AU (1) AU2001278797A1 (de)
DE (1) DE60140218D1 (de)
ES (1) ES2333774T3 (de)
WO (1) WO2002014525A2 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2435972C (en) * 2001-01-26 2011-09-13 University Of Lausanne Matrix attachment regions and methods for use thereof
PL210412B1 (pl) 2002-05-24 2012-01-31 Schering Corp Izolowane przeciwciało anty-IGFR lub jego fragment, kompozycja farmaceutyczna, zastosowanie, kwas nukleinowy, zrekombinowany wektor, komórka gospodarza, kompleks, polipeptyd i sposób jego wytwarzania
AU2003263161A1 (en) * 2002-09-20 2004-04-08 Novo Nordisk A/S Method for making recombinant proteins
US6933136B2 (en) 2002-09-20 2005-08-23 Novo Nordisk A/S Method for making recombinant proteins
KR100755931B1 (ko) * 2003-06-11 2007-09-06 (주)두비엘 고분자형 만노스 결합형 렉틴의 대량 생산방법 및 상기방법으로 제조된 만노스 결합형 렉틴 재조합 단백질의제제화
US7135338B2 (en) * 2003-06-11 2006-11-14 Dobeel Corporation Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism
CA2535836C (en) 2003-10-24 2014-02-04 Nicolas Mermod High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences
WO2005047512A2 (en) * 2003-11-12 2005-05-26 Shering Corporation Plasmid system for multigene expression
AR046639A1 (es) 2003-11-21 2005-12-14 Schering Corp Combinaciones terapeuticas de anticuerpo anti- igfr1
WO2006046786A1 (en) * 2004-10-28 2006-05-04 Dobeel Co., Ltd. Method for the mass production of multimeric mannose binding lectin
EP1859046B1 (de) * 2005-03-04 2010-06-16 Celltrion, Inc. Expressionsvektor für tierische zelle mit wenigstens einer kopie von mar-dna-sequenzen am 3'-ende des transkriptionsterminationsbereichs eines gens sowie verfahren zur expression eines fremdgens unter verwendung des vektors
KR100779761B1 (ko) * 2005-10-28 2007-11-30 대한민국 인슐린 억제 및 사람 ｉｄｅ 유전자로 형질전환된 동물 및그 제조방법
KR100836745B1 (ko) * 2007-01-31 2008-06-10 (주)두비엘 Ｈｂｖ 백신 및 그의 제조 방법
KR101258949B1 (ko) 2007-06-15 2013-04-30 재단법인 목암생명공학연구소 활성형 재조합 혈액응고 9인자의 대량생산 방법
CN101348786B (zh) * 2007-07-20 2011-05-11 谭孟群 一种人β珠蛋白基因及其重组腺相关病毒载体
US20110195451A1 (en) * 2008-06-10 2011-08-11 Isis Innovation Limited Protein Expression
KR101054362B1 (ko) 2008-07-03 2011-08-05 재단법인 목암생명공학연구소 재조합 단백질의 푸코스 함량을 감소시키는 방법
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
US20120064631A1 (en) * 2009-03-27 2012-03-15 Hiroshima University Method for amplification and high-level expression of target gene in mammalian cell, and kit for achieving the method
KR20120099376A (ko) * 2009-09-18 2012-09-10 셀렉시스 에스. 에이. 강화된 전이 유전자 발현과 공정 방법 및 그 산물
CN102639699A (zh) * 2009-10-01 2012-08-15 Toto株式会社 Dna构建体以及用其制备重组cho细胞的方法
US20130034875A1 (en) * 2009-10-01 2013-02-07 Toto Ltd. Dna construct, and process for production of recombinant cho cell using same
BR112013008459A2 (pt) 2010-10-08 2016-06-28 Cadila Healthcare Ltd ''vetor de expressão,célula hospedeira,processo para a produção de proteinas e de peptideos e dos variantes dos mesmos''
JP5931174B2 (ja) * 2011-03-30 2016-06-08 パンジェン バイオテク インコーポレイテッド 動物細胞発現ベクター
JP5972866B2 (ja) 2011-03-31 2016-08-17 クニミネ工業株式会社 タンパク質結晶化条件探索剤及びタンパク質結晶化条件探索方法
KR101420274B1 (ko) * 2011-06-13 2014-07-21 주식회사 종근당 Ｃｓｐ－ｂ ５＇ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법
CA2849318C (en) 2011-09-22 2019-11-12 Amgen Inc. Cd27l antigen binding proteins
CN104011075B (zh) * 2011-12-22 2017-06-06 弗·哈夫曼-拉罗切有限公司 表达载体元件组合、新的生产用细胞产生方法及其在重组产生多肽中的用途
SG11201403223PA (en) 2011-12-22 2014-07-30 Hoffmann La Roche Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides
UY34813A (es) 2012-05-18 2013-11-29 Amgen Inc Proteínas de unión a antígeno dirigidas contra el receptor st2
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9546203B2 (en) 2013-03-14 2017-01-17 Amgen Inc. Aglycosylated Fc-containing polypeptides with cysteine substitutions
WO2014144817A2 (en) 2013-03-15 2014-09-18 Amgen Inc. Inhibitory polypeptides specific to wnt inhibitors
CN103194455B (zh) * 2013-04-08 2014-10-15 山东省农业科学院畜牧兽医研究所 高效表达的猪粒细胞巨噬细胞集落刺激因子基因及其表达蛋白的用途
IL317484A (en) 2013-05-30 2025-02-01 Kiniksa Pharmaceuticals Ltd Oncostatin M receptor antigen-binding proteins
CA2923145C (en) 2013-09-05 2025-09-16 Amgen Inc. MOLECULES CONTAINING FCS AND EXHIBITING PREDICTABLE, UNIFORM AND REPRODUCIBLE GLYCOFORM PROFILES
AU2014317961B2 (en) 2013-09-05 2020-07-30 Murdoch University Antisense-induced exon2 inclusion in acid alpha-glucosidase
KR101591823B1 (ko) 2013-12-27 2016-02-04 재단법인 목암생명공학연구소 증가된 유전자 발현능을 갖는 발현벡터
EA201792250A1 (ru) 2015-04-10 2018-05-31 Эмджен Инк. Мутеины интерлейкина-2 для роста регуляторных т-клеток
WO2016164937A2 (en) 2015-04-10 2016-10-13 Amgen Inc. Interleukin-2 muteins for the expansion of t-regulatory cells
CA2980189A1 (en) 2015-04-24 2016-10-27 Genentech, Inc. Multispecific antigen-binding proteins
MX2018003445A (es) 2015-09-22 2018-08-01 Genentech Inc Expresion de proteinas que contienen fc.
EP4524161A3 (de) 2015-10-08 2025-06-04 Zymeworks BC Inc. Antigenbindende polypeptidkonstrukte mit kappa- und lambda-leichtketten und verwendungen davon
SG11201802773RA (en) 2015-11-02 2018-05-30 Genentech Inc Methods of making fucosylated and afucosylated forms of a protein
BR112018071477A2 (pt) 2016-04-18 2019-02-19 Sarepta Therapeutics, Inc. oligômeros antisenso e métodos de utilização dos mesmos para tratamento de doenças associadas com o gene da alfa-glicosidase ácida
WO2018150345A1 (en) * 2017-02-16 2018-08-23 De Vita Bio Life Sciences An expression vector
US11965019B2 (en) 2017-06-30 2024-04-23 Zymeworks Bc Inc. Stabilized chimeric Fabs
CN110343718A (zh) * 2018-04-03 2019-10-18 新乡医学院 一种高效稳定的细胞表达载体、表达系统及其制备方法、应用
AU2020328038B2 (en) 2019-08-13 2025-10-09 Amgen Inc. Interleukin-2 muteins for the expansion of T-regulatory cells
MX2022007712A (es) 2019-12-17 2022-09-26 Amgen Inc Agonista doble de interleucina-2/receptor de tnf para uso en terapia.
AU2024307352A1 (en) 2023-06-27 2025-12-11 Amgen Inc. Charge pair mutations to enable correct heavy-light chain pairing

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
EP0663921B1 (de) 1992-10-05 2002-05-08 North Carolina State University Verfahren zur erhöhung der expression und zur verminderung der expressionsvariabilität von fremdgenen in pflanzenzellen
US5738985A (en) * 1993-04-02 1998-04-14 Ribogene, Inc. Method for selective inactivation of viral replication
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
WO1997046687A1 (en) * 1996-06-06 1997-12-11 Novartis Ag Vectors comprising sar elements
EP0914454B1 (de) 1996-06-11 2005-03-09 Pioneer Hi-Bred International, Inc. Ein synthetischer, pflanzlicher kernpromotor und stromaufwaerts gelegenes, regulatorisches element
US6245974B1 (en) 1997-08-06 2001-06-12 North Carolina State University Matrix attachment regions
KR100313559B1 (ko) * 1998-07-22 2002-03-08 허영섭 수용성 TGFβ 수용체를 발현하는 재조합 세포주 및 전기세포주를 이용한 암치료 방법
EP1117815A1 (de) * 1998-09-29 2001-07-25 Pioneer Hi-Bred International Inc. Mar/sar elemente, die ein durch rsyn7 reguliertes konstrukt flankieren
CA2435972C (en) * 2001-01-26 2011-09-13 University Of Lausanne Matrix attachment regions and methods for use thereof

Also Published As

Publication number Publication date
JP2004506428A (ja) 2004-03-04
DE60140218D1 (de) 2009-11-26
US20040038394A1 (en) 2004-02-26
WO2002014525A2 (en) 2002-02-21
CN1444657A (zh) 2003-09-24
EP1392835A2 (de) 2004-03-03
KR100408844B1 (ko) 2003-12-06
WO2002014525A3 (en) 2003-11-20
EP1392835B1 (de) 2009-10-14
CN1262663C (zh) 2006-07-05
ES2333774T3 (es) 2010-03-01
US7422874B2 (en) 2008-09-09
JP4138479B2 (ja) 2008-08-27
EP1392835A4 (de) 2006-04-19
AU2001278797A1 (en) 2002-02-25
KR20020010327A (ko) 2002-02-04

Similar Documents

Publication Publication Date Title
DE60140218D1 (de) Expressionsvektor für tierische zellen
WO1999040197A3 (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
ATE440951T1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
DE69939839D1 (de) Expressionssystem für faktor viii
ATE474926T1 (de) Verwendung von clya hemolysin fur ausscheidung von fusionprotein
DE60041243D1 (de) Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins
DE50009838D1 (de) Humanes antibiotisches protein
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
EA200000270A1 (ru) КОМПОЗИЦИИ ДЛЯ ГЕНОТЕРАПИИ С ИСПОЛЬЗОВАНИЕМ ГЕНОВ, КОДИРУЮЩИХ СЕКРЕТИРУЕМЫЕ БЕЛКИ, ТАКИЕ КАК β-ИНТЕРФЕРОН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
EP1065214A4 (de) Neue, physiologisch aktive peptide und ihre verwendung.
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
DK1287134T3 (da) Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf
MY143222A (en) Expression vector for animal cell
NO20023015D0 (no) Humant heparanasebeslektet polypeptid og nukleinsyre
DK0811068T3 (da) Humane DNase I varianter
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
EP1140968A4 (de) Dna-moleküle kodierende spleissvarianten des humanen melanocortin-1-rezeptorproteins
NO991227L (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2
ATE366261T1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
ATE346926T1 (de) Menschliche twik-8 moleküle und ihre verwendung
FR2862660B1 (fr) Systeme d'expression inductible de proteines recombinantes chez les cyanobacteries.
DE69631624D1 (de) Antikörper gegen menschliches restrictin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties